Critical illness after horizontal nosocomial transmission of human metapneumovirus in the haematology ward

Netherlands Journal of Critical Care

Volumn 16, Issue 1, 2012, Pages 22-25

  van Dijk, N M ^a   Linssen, C F M ^a   Bussink, M ^a   Span, L F R ^b   van Mook, W N K A ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Critically ill; HMPV; Human metapneumovirus; Stem cell transplantation

Indexed keywords

IMMUNOGLOBULIN; NORADRENALIN; PIPERACILLIN PLUS TAZOBACTAM; RIBAVIRIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; CONTINUOUS HEMOFILTRATION; CRITICAL ILLNESS; DIARRHEA; DISEASE TRANSMISSION; FEVER; FLUID RESUSCITATION; HOSPITAL INFECTION; HUMAN; HUMAN METAPNEUMOVIRUS; HUMAN METAPNEUMOVIRUS INFECTION; HYPOTENSION; INTENSIVE CARE UNIT; INTUBATION; KIDNEY FAILURE; LUNG INFILTRATE; MALE; MANTLE CELL LYMPHOMA; MULTIPLE MYELOMA; NEUTROPENIA; PNEUMONIA; RESPIRATORY FAILURE; TACHYCARDIA;

EID: 84860155268     PISSN: 15693511     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Pabbaraju K, Wong S, McMillan T, et al: Diagnosis and epidemiological studies of human metapneumovirus using real-time PCR. J Clin Virol 2007; 40:186-92.
2. van den Hoogen BG, de Jong JC, Groen J, et al: A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001; 7:719-24.
3. Sumino KC, Agapov E, Pierce RA, et al: Detection of severe human metapneumovirus infection by real-time polymerase chain reaction and histopathological assessment. J Infect Dis 2005; 192:1052-60.
4. Boivin G, Mackay I, Sloots TP, et al: Global genetic diversity of human metapneumovirus fusion gene. Emerg Infect Dis 2004; 10:1154-7.
5. Peret TC, Abed Y, Anderson LJ, et al: Sequence polymorphism of the predicted human metapneumovirus G glycoprotein. J Gen Virol 2004; 85:679-86.
6. Sloots TP, Mackay IM, Bialasiewicz S, et al: Human metapneumovirus, Australia, 2001- 2004. Emerg Infect Dis 2006; 12:1263-6.
7. Ebihara T, Endo R, Kikuta H, et al: Seroprevalence of human metapneumovirus in Japan. J Med Virol 2003; 70:281-3.
8. Wolf DG, Zakay-Rones Z, Fadeela A, et al: High seroprevalence of human metapneumovirus among young children in Israel. J Infect Dis 2003; 188:1865-7.
9. Hamelin ME, Prince GA, Gomez AM, et al: Human metapneumovirus infection induces long-term pulmonary inflammation associated with airway obstruction and hyperresponsiveness in mice. J Infect Dis 2006; 193:1634-42.
10. van den Hoogen BG, Osterhaus DM, Fouchier RA. Clinical impact and diagnosis of human metapneumovirus infection. Pediatr Infect Dis J 2004; 23:S25-32.
11. Englund JA, Boeckh M, Kuypers J, et al: Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients. Ann Intern Med 2006; 144:344-9.
12. Jacobs JA, De Brauwer E. BAL fluid cytology in the assessment of infectious lung disease. Hosp Med 1999; 60:550-5.
13. Soubani AO, Kseibi E, Bander JJ et al: Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU. Chest 2004; 126: 1604-11.
14. Huynh TN, Weigt SS, Belperio JA. Outcome and prognostic indicators of patients with hematopoietic stem cell transplants admitted to the intensive care unit. J Transplant 2009; 917297.
15. Hayani O, Beihany AAl, Zarychanski R et al: Impact of critical care outreach on hematopoietic stem cell transplant recipients: a cohort study. Bone Marrow transpl 2010; 25:1-7.
16. Geerse DA, Span LFR, Pinto-Sietsma SJ et al: Prognosis of haematological malignancies admitted to the intensive care unit: Sequential Organ Failure Assessment (SOFA) trend is a powerful predictor of mortality. Eur J Int Med 2011; 22:57-61
17. Price KJ, Thall PF, Kish SK et al: Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J of Respir Crit Care Med 1998; 876-84.
18. Huaringa AJ, Leyva FJ, Giralt SA et al: Outcome of bone marrow transplantation patients requiring mechanical ventilation. Crit Care Med 2000; 28:1014-17.
19. Lim do H, Lee J, Lee HG, et al: Pulmonary complications after haematopoietic stem cell transplantation. J Korean Med Sci 2006; 21:406-11.
20. Watkins TR, Chien JW, Crawford SW. Graft versus host-associated pulmonary disease and other idiopathic pulmonary complications after haematopoietic stem cell transplant. Semin Respir Crit Care Med 2005; 26:482-9.
21. Afessa B, Peters SG. Major complications following haematopoietic stem cell transplantation. Semin Respir Crit Care Med 2006; 27:297-309.
22. Kim EA, Lee KS, Primack SL, et al: Viral pneumonias in adults: radiologic and pathologic findings. Radiographics 2002; 22:S137-49.
23. Cane PA, van den Hoogen BG, Chakrabarti S, et al: Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease. Bone Marrow Transplant 2003; 31:309-10.
24. Huck B, Egger M, Bertz H, et al: Human metapneumovirus infection in a haematopoietic stem cell transplant recipient with relapsed multiple myeloma and rapidly progressing lung cancer. J Clin Microbiol 2006; 44:2300-3.
25. O'Gorman C, McHenry E, Coyle PV. Human metapneumovirus in adults: a short case series. Eur J Clin Microbiol Infect Dis 2006; 25:190-2.
26. Demers RR. Bacterial/viral filtration: let the breather beware! Chest 2001; 120:1377-89.
27. Menzies D, Popa J, Hanley JA, et al: Effect of ultraviolet germicidal lights installed in office ventilation systems on workers' health and wellbeing: double-blind multiple crossover trial. Lancet 2003; 362:1785-91.
28. File TM. Community-acquired pneumonia. Lancet 2003; 362:1991-2001.
29. Carrat F, Leruez-Ville M, Tonnellier M, et al: A virologic survey of patients admitted to a critical care unit for acute cardiorespiratory failure. Intensive Care Med 2006; 32:156-9.
30. Raza K, Ismailjee SB, Crespo M, et al: Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin. J Heart Lung Transplant 2007; 26:862-4.
31. Wyde PR, Chetty SN, Jewell AM, et al.: Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antiviral Res 2003; 60:51-9.